# CORRESP — Entero Therapeutics, Inc.  (GRDX)  (CIK 0001604191)

> <strong>Entero Therapeutics, Inc.  (GRDX)  (CIK 0001604191) → SEC staff</strong> · filed 2025-09-10 · ticker GRDX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-25-089121
- **Form:** CORRESP
- **Filer:** Entero Therapeutics, Inc.  (GRDX)  (CIK 0001604191)
- **CIK:** 0001604191
- **Ticker:** GRDX
- **Filed:** 2025-09-10
- **SIC industry:** 2834
- **HQ:** Boca Raton, FL

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1604191/000110465925089121/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1604191&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for Entero Therapeutics, Inc.  (GRDX)  (CIK 0001604191)

- CORRESP — 2025-09-11 — /comment-letter/0001410578-25-002111

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Entero Therapeutics, Inc.  (GRDX)  (CIK 0001604191) (CIK 0001604191), filed 2025-09-10, accession 0001104659-25-089121. Retrieved via MORVS 2026-11-05 from https://api.morvs.ai/comment-letter/0001104659-25-089121.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*